National Bank Of Canada Imv Inc. Transaction History

National Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 13, 2022	BUY	$0.47 - $0.75 $2.06 Million - $3.29 Million	4,387,397 Added 460.66%	5,339,807 $2.96 Million
Q2 2022 Jul 28, 2022	SELL	$0.56 - $1.45 $57,736 - $149,495	-103,100 Reduced 9.77%	952,410 $617,000
Q1 2022 May 05, 2022	SELL	$1.07 - $1.5 $36,650 - $51,379	-34,253 Reduced 3.14%	1,055,510 $1.47 Million
Q4 2021 Jan 24, 2022	BUY	$1.22 - $1.78 $1.33 Million - $1.94 Million	1,089,763 New	1,089,763 $1.33 Million

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.